Apoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic field

Int J Nanomedicine. 2014 Apr 23:9:2043-50. doi: 10.2147/IJN.S60457. eCollection 2014.

Abstract

Objective: To explore the effect of folic acid-modified magnetic nanoparticles (FA-MNPs) combined with a 100 Hz extremely low-frequency electromagnetic field (ELF-EMF) on the apoptosis of liver cancer BEL-7402 cells.

Materials and methods: MNPs (20 nm) were prepared by coprecipitation, and then folic acid was coated onto MNPs to prepare FA-MNPs. BEL-7402 cells and HL7702 cells were selected as liver cancer cells and normal liver cells, respectively. The ELF-EMF was generated from a solenoid coil. Cellular uptake of NPs was determined by inductively coupled plasma atomic emission spectroscopy. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to evaluate cell inhibition. Apoptosis was analyzed by flow cytometry. Statistical analyses were performed using two-way analysis of variance.

Results: FA-MNPs combined with a 100 Hz magnetic field significantly inhibited cell proliferation and induced higher apoptosis compared to either the ELF-EMF alone or FA-MNPs alone. FA-MNPs showed a better apoptosis effect and higher iron uptake in BEL-7402 cells compared to in HL7702 cells. On the basis of the ELF-EMF, higher doses of FA-MNPs brought higher apoptosis and higher iron uptake in either BEL-7402 cells or HL7702 cells.

Conclusion: These results suggest that FA-MNPs may induce apoptosis in a cellular iron uptake-dependent manner when combined with an ELF-EMF in BEL-7402 cells.

Keywords: apoptosis; extremely low-frequency magnetic field; folic acid; liver cancer; magnetic nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Apoptosis / drug effects*
  • Apoptosis / radiation effects*
  • Chemoradiotherapy / methods*
  • Folic Acid / administration & dosage*
  • Folic Acid / chemistry
  • Humans
  • Magnetic Field Therapy / methods*
  • Magnetic Fields
  • Magnetite Nanoparticles / administration & dosage*
  • Magnetite Nanoparticles / chemistry
  • Magnetite Nanoparticles / radiation effects
  • Nanocapsules / administration & dosage
  • Nanocapsules / chemistry
  • Nanocapsules / radiation effects
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Magnetite Nanoparticles
  • Nanocapsules
  • Folic Acid